[Federal Register Volume 61, Number 39 (Tuesday, February 27, 1996)]
[Notices]
[Page 7265]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-4575]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advisory Committee Meetings; Amendment of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing 
amendments to the notice of meetings of the Antiviral Drugs Advisory 
Committee, the Endocrinologic and Metabolic Drugs Advisory Committee, 
and the joint meeting of the Endocrinologic and Metabolic Drugs 
Advisory Committee and the Antiviral Drugs Advisory Committee. These 
meetings were announced in the Federal Register of January 31, 1996 (61 
FR 3427). The amendments reflect a change in the location of the 
Antiviral Drugs Advisory Committee meeting on the third day. The 3-day 
meeting will now be held at the same location. In addition, the 
location has been changed for the other meetings. There are no other 
changes. The amendments will be announced at the beginning of the open 
portion of the meetings.

FOR FURTHER INFORMATION CONTACT:
     For the Antiviral Drugs Advisory Committee Meeting: Ermona 
McGoodwin, Center for Drug Evaluation and Research (HFD-21), Food and 
Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-
5455.
     For both the Endocrinologic and Metabolic Drugs Advisory Committee 
Meeting and the Joint Meeting of the Endocrinologic and Metabolic Drugs 
Advisory Committee and the Antiviral Drugs Advisory Committee: Kathleen 
R. Reedy, Center for Drug Evaluation and Research (HFD-21), Food and 
Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-
5455.

SUPPLEMENTARY INFORMATION: In the Federal Register of January 31, 1996 
(61 FR 3427), FDA announced: (1) A meeting of the Antiviral Drugs 
Advisory Committee would be held on February 28 and 29, and March 1, 
1996; (2) a meeting of the Endocrinologic and Metabolic Drugs Advisory 
Committee would be held on February 29, 1996; and (3) a joint meeting 
of the Endocrinologic and Metabolic Drugs Advisory Committee and the 
Antiviral Drugs Advisory Committee would be held on March 1, 1996. On 
page 3428, beginning in the second column, the ``Date, time, and 
place'' portion of the Antiviral Drugs Advisory Committee is amended to 
read as follows:
    -Date, time, and place. February 28 and 29, and March 1, 1996, 8:30 
a.m., Holiday Inn--Gaithersburg, Grand Ballroom, Two Montgomery Village 
Ave., Gaithersburg, MD.
     On page 3429, in the first column, the ``Date, time, and place'' 
portion of the Endocrinologic and Metabolic Drugs Advisory Committee is 
amended to read as follows:
    Date, time, and place. February 29, 1996, 8 a.m., Holiday Inn--
Silver Spring, Plaza Ballroom, 8777 Georgia Ave., Silver Spring, MD.
     On the same page, in the second column, the ``Date, time, and 
place'' portion of the joint meeting of the Endocrinologic and 
Metabolic Drugs Advisory Committee and the Antiviral Drugs Advisory 
Committee is amended to read as follows:
    -Date, time, and place. March 1, 1996, 8 a.m., Holiday Inn--Silver 
Spring, Plaza Ballroom, 8777 Georgia Ave., Silver Spring, MD.

    Dated: February 22, 1996.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 96-4575 Filed 2-23-96; 4:12 pm]
BILLING CODE 4160-01-F